MD

Pediatrix Medical Group, Inc.
CAPPED RATING

Mednax Inc is a provider of physician services that are newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. Anesthesiology and Neonatology and other pediatric subspecialties generate more income.

Pediatrix Medical Group, Inc. (MD) is rated C (2.3/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B+); its weakest is Revisions (F). The rating has held at C for 8 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.3 / 5.0
C
Value
B
Factor Score 3.2 / 5.0
Growth
D+
Factor Score 1.8 / 5.0
Profitability
B-
Factor Score 3.1 / 5.0
Momentum
B+
Factor Score 3.6 / 5.0
Revisions
F
Factor Score 0.0 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 17.2
EV / EBITDA 9.9
Rev Growth YoY 1.7%
Gross Margin 26.1%
Price Return 3M 18.0%
Price Return 12M 38.9%
Catalyst Signal 0.00
Market Cap $2.5B
TTM Revenue $2.0B
Price / Sales 1.3
ROE 17.2%

Historical Factor Score Progression

Held C for 8 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 B (3.2) D+ (1.8) B- (3.1) B+ (3.6) F (0.0) C (2.3)
2026-11-06 B- (3.1) D+ (1.8) B- (3.1) B (3.5) F (0.0) C (2.3)
2026-10-30 B (3.2) C- (1.9) B- (3.1) B (3.3) F (0.0) C (2.3)
2026-10-23 B (3.2) C- (1.9) B- (3.1) B (3.2) F (0.0) C (2.3)
2026-10-16 B (3.2) C- (1.9) B- (3.1) B (3.2) F (0.0) C (2.3)
Page 1 of 5